492 related articles for article (PubMed ID: 29288700)
1. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
[TBL] [Abstract][Full Text] [Related]
2. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
[TBL] [Abstract][Full Text] [Related]
4. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
[TBL] [Abstract][Full Text] [Related]
6. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus
Li Z; Lang Y; Sakamuru S; Samrat S; Trudeau N; Kuo L; Rugenstein N; Tharappel A; D'Brant L; Koetzner CA; Hu S; Zhang J; Huang R; Kramer LD; Butler D; Xia M; Li H
Emerg Microbes Infect; 2020 Dec; 9(1):2404-2416. PubMed ID: 33078696
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
[TBL] [Abstract][Full Text] [Related]
9. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of ten NS2B-NS3 proteases: Paving the way for pan-flavivirus drugs.
Voss S; Rademann J; Nitsche C
Antiviral Res; 2024 Jun; 226():105878. PubMed ID: 38582134
[TBL] [Abstract][Full Text] [Related]
11. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
[TBL] [Abstract][Full Text] [Related]
12. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
[TBL] [Abstract][Full Text] [Related]
13. Identification and enzymatic characterization of NS2B-NS3 protease of Alkhurma virus, a class-4 flavivirus.
Bessaud M; Grard G; Peyrefitte CN; Pastorino B; Rolland D; Charrel RN; de Lamballerie X; Tolou HJ
Virus Res; 2005 Jan; 107(1):57-62. PubMed ID: 15567034
[TBL] [Abstract][Full Text] [Related]
14. Strategies Towards Protease Inhibitors for Emerging Flaviviruses.
Nitsche C
Adv Exp Med Biol; 2018; 1062():175-186. PubMed ID: 29845533
[TBL] [Abstract][Full Text] [Related]
15. Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors.
Akaberi D; Båhlström A; Chinthakindi PK; Nyman T; Sandström A; Järhult JD; Palanisamy N; Lundkvist Å; Lennerstrand J
Antiviral Res; 2021 Jun; 190():105074. PubMed ID: 33872674
[TBL] [Abstract][Full Text] [Related]
16. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development.
Luo D; Vasudevan SG; Lescar J
Antiviral Res; 2015 Jun; 118():148-58. PubMed ID: 25842996
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.
Nie S; Zhao J; Wu X; Yao Y; Wu F; Lin YL; Li X; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
Eur J Med Chem; 2021 Dec; 225():113767. PubMed ID: 34450494
[TBL] [Abstract][Full Text] [Related]
18. The flavivirus protease as a target for drug discovery.
Brecher M; Zhang J; Li H
Virol Sin; 2013 Dec; 28(6):326-36. PubMed ID: 24242363
[TBL] [Abstract][Full Text] [Related]
19. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
[TBL] [Abstract][Full Text] [Related]
20. NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues.
El Sahili A; Soh TS; Schiltz J; Gharbi-Ayachi A; Seh CC; Shi PY; Lim SP; Lescar J
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
